Structures by: Cobo J.
Total: 558
(2<i>S</i>,4<i>R</i>)-7-fluoro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-\ tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2010) 66, 4 o206-o208
a=10.052(4)Å b=5.299(4)Å c=12.976(8)Å
α=90.00° β=91.10(4)° γ=90.00°
5-Amino-1-benzoyl-3-methylpyrazole
C11H11N3O
Acta Crystallographica Section C (2010) 66, 4 o159-o162
a=14.7443(6)Å b=5.7669(2)Å c=12.0082(3)Å
α=90.00° β=106.119(2)° γ=90.00°
<i>N</i>-(3-<i>tert</i>-butyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-chloro- <i>N</i>-(4-methoxybenzyl)acetamide
C23H26ClN3O2
Acta Crystallographica Section C (2010) 66, 4 o168-o173
a=10.0761(12)Å b=10.5208(8)Å c=11.1868(19)Å
α=96.546(7)° β=95.790(9)° γ=116.035(9)°
2-amino-4-(piperidin-1-yl)-11<i>H</i>-pyrimido[4,5-<i>b</i>][1,5]benzodiazepin- 6-ium chloride monohydrate
C16H19N6,Cl,H2O
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=13.7831(14)Å b=7.5324(9)Å c=15.2987(12)Å
α=90.00° β=94.925(8)° γ=90.00°
2-amino-4-[methyl(2-methylphenyl)amino]-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,5]benzodiazepin-6-ium chloride--benzene-1,2-diamine (1/1)
C19H19N6,Cl,C6H8N2
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=10.9559(13)Å b=11.2372(13)Å c=11.432(2)Å
α=102.894(12)° β=112.176(14)° γ=107.512(10)°
<i>N</i>-(3-<i>tert</i>-butyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-chloro- <i>N</i>-(4-chlorobenzyl)acetamide
C22H23Cl2N3O
Acta Crystallographica Section C (2010) 66, 4 o168-o173
a=10.120(2)Å b=10.7732(18)Å c=19.2751(14)Å
α=90.00° β=95.662(9)° γ=90.00°
<i>S</i>-[<i>N</i>-(3-<i>tert</i>-butyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)- <i>N</i>-(4-methylbenzyl)carbamoyl]methyl <i>O</i>-ethyl carbonodithioate
C26H31N3O2S2
Acta Crystallographica Section C (2010) 66, 4 o168-o173
a=9.6847(14)Å b=11.3127(9)Å c=12.3425(12)Å
α=77.040(8)° β=72.789(9)° γ=84.977(9)°
(<i>E</i>)-<i>N</i>^2^-{4-[(<i>E</i>)-2-(4-Chlorobenzoyl)ethenyl]-3-methyl- 1-phenyl-1<i>H</i>-pyrazol-5-yl}-<i>N</i>^1^,<i>N</i>^1^-dimethylformamidine
C22H21ClN4O
Acta Crystallographica Section C (2010) 66, 5 o245-o248
a=8.2228(3)Å b=8.3506(2)Å c=28.7043(10)Å
α=90.00° β=90.00° γ=90.00°
Benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline-5,6(10<i>H</i>)-dione
C27H17N3O2
Acta Crystallographica Section C (2010) 66, 6 o305-o309
a=15.436(5)Å b=13.622(7)Å c=9.359(5)Å
α=90.00° β=105.00(4)° γ=90.00°
8-methyl-7-(4-methylphenyl)-10-phenyl-5<i>H</i>- benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline-5,6(10<i>H</i>)-dione
C28H19N3O2
Acta Crystallographica Section C (2010) 66, 6 o305-o309
a=8.9952(15)Å b=9.6201(15)Å c=12.537(4)Å
α=98.72(2)° β=103.31(2)° γ=95.48(2)°
2-exo-(4-chlorophenyl)-2,3,4,5-tetrahydro-1<i>H</i>- 1,4-epoxy-1-benzazepine
C16H14ClNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=8.2405(14)Å b=11.5432(16)Å c=27.442(2)Å
α=90.00° β=101.030(13)° γ=90.00°
2-exo-(3-methylphenyl)-2,3,4,5-tetrahydro-1<i>H</i>-1,4- epoxy-1-benzazepine
C17H17NO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.9966(17)Å b=23.691(10)Å c=10.6323(8)Å
α=90.00° β=111.661(8)° γ=90.00°
2-exo-(4-bromophenyl)-7-chloro-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H13BrClNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=15.3626(16)Å b=11.5436(13)Å c=7.8832(13)Å
α=90.00° β=96.080(11)° γ=90.00°
(2<i>RS</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>endo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H18ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.2890(9)Å b=9.3076(16)Å c=13.551(3)Å
α=94.554(15)° β=94.684(15)° γ=97.298(14)°
(2<i>SR</i>,4<i>RS</i>)-7-chloro-2-<i>exo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C14H16ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=5.6445(5)Å b=25.744(3)Å c=8.3894(11)Å
α=90.00° β=95.124(9)° γ=90.00°
5-Acetyl-2-chloro-8,11-dimethyl-5,6,11,12- tetrahydrodibenzo[<i>b</i>,<i>f</i>]azocine
C19H20ClNO
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=8.3396(3)Å b=21.7131(7)Å c=9.2010(3)Å
α=90.00° β=106.683(2)° γ=90.00°
14-acetyl-8,11-dimethyl-7,8,13,14- tetrahydrobenzo[<i>f</i>]naphtho[1,2-<i>b</i>]azocine--14-acetyl- 8,9-dimethyl-7,8,13,14-tetrahydrobenzo[<i>f</i>]naphtho[1,2-<i>b</i>]azocine (74/26)
C23H23NO
Acta Crystallographica Section C (2010) 66, 6 o284-o288
a=18.9549(10)Å b=9.8917(4)Å c=9.4354(5)Å
α=90.00° β=97.348(3)° γ=90.00°
(Z)-5-(2-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=11.1848(4)Å b=7.7651(4)Å c=12.3611(5)Å
α=90.00° β=107.417(3)° γ=90.00°
(Z)-5-(4-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=4.9173(2)Å b=19.8906(10)Å c=10.4976(6)Å
α=90.00° β=92.929(3)° γ=90.00°
(Z)-5-(3,4,5-Trimethoxybenzylidene)-2-thioxothaolidin-2-one
C13H13NO4S2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=10.3432(4)Å b=10.9105(4)Å c=13.4621(4)Å
α=100.399(2)° β=91.572(2)° γ=110.301(2)°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-diphenylpentane-1,5-dione
C27H23ClN2O2
Acta Crystallographica Section C (2006) 62, 8 o518-o520
a=15.2964(3)Å b=17.4366(2)Å c=16.8320(3)Å
α=90.00° β=90.00° γ=90.00°
N-(6-amino-3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)- N-[β-D-glucopyranosyl]acetamide
C13H20N4O8,2H2O1
Acta Crystallographica Section C (2000) 56, 9 e420-e420
a=7.09110(10)Å b=12.2566(2)Å c=20.5272(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)benzoate
C13H15N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=7.2228(4)Å b=8.4433(3)Å c=10.5938(5)Å
α=98.234(3)° β=107.609(2)° γ=97.907(3)°
Methyl 4-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)benzoate
C15H19N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=6.1272(2)Å b=11.6374(3)Å c=20.3182(7)Å
α=90.00° β=98.629(2)° γ=90.00°
3-tert-butyl-5-[(4-methoxybenzyl)amino]-1-phenyl-1H-pyrazole
C21H25N3O
Acta Crystallographica Section C (2007) 63, 1 o29-o32
a=10.9665(14)Å b=10.9665(14)Å c=30.796(6)Å
α=90.00° β=90.00° γ=90.00°
5-[(benzotriazol-1-ylmethyl)(4-methoxybenzyl)amino]-3-tert-butyl-1- phenyl-1H-pyrazole
C28H30N6O
Acta Crystallographica Section C (2007) 63, 1 o29-o32
a=12.5184(2)Å b=18.5142(5)Å c=21.7580(5)Å
α=90.00° β=96.0730(15)° γ=90.00°
7-Amino-2-tert-butyl-5-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2007) 63, 1 o26-o28
a=10.8271(2)Å b=10.8271(2)Å c=19.9208(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-[(5-methyl-1H-pyrazol-3-yl)amino]-3-nitrobenzoate
C12H12N4O4
Acta Crystallographica Section C (2007) 63, 1 o38-o41
a=5.9233(3)Å b=8.8858(6)Å c=11.7819(6)Å
α=85.690(4)° β=83.500(4)° γ=84.015(3)°
Methyl 1-(5-methyl-1H-pyrazol-3-yl)-1H-benzimidazole-5-carboxylate
C13H12N4O2
Acta Crystallographica Section C (2007) 63, 1 o38-o41
a=8.3646(3)Å b=11.5735(6)Å c=12.7953(7)Å
α=88.328(3)° β=88.526(3)° γ=75.362(3)°
2-methoxy-4-(pyrrolo[1,2-<i>a</i>]quinoxalin-4-yl)phenol
C18H14N2O2
Acta Crystallographica Section C (2010) 66, 8 o385-o388
a=7.9278(8)Å b=15.2929(18)Å c=22.410(4)Å
α=90.00° β=90.326(12)° γ=90.00°
2-methoxy-4-(pyrrolo[1,2-<i>a</i>]quinoxalin-4-yl)phenol
C18H14N2O2
Acta Crystallographica Section C (2010) 66, 8 o385-o388
a=7.9278(8)Å b=15.2929(18)Å c=22.410(4)Å
α=90.00° β=90.326(12)° γ=90.00°
(9E)-9-benzylidene-3-methyl-2-(methylthio)-5-phenyl- 5,6,7,8,9,10-hexahydropyrimido[4,5-<i>b</i>]quinolin- 4(3<i>H</i>)-one
C26H25N3OS
Acta Crystallographica Section C (2010) 66, 8 o389-o391
a=8.382(2)Å b=10.777(3)Å c=12.745(4)Å
α=73.18(3)° β=85.13(4)° γ=76.43(3)°
7-amino-5-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=9.8216(5)Å b=11.3582(7)Å c=12.2783(8)Å
α=70.429(3)° β=69.895(4)° γ=66.454(4)°
3-(4-Methoxyphenyl)-7,7-dimethyl-1,6,7,8-tetrahydropyrazolo[3,4-b]quinolin-5-one
C19H19N3O2
Acta Crystallographica Section C (2006) 62, 8 o525-o527
a=7.1510(6)Å b=9.7680(7)Å c=12.3780(8)Å
α=72.094(5)° β=83.529(4)° γ=85.055(4)°
2-Benzyl-3-(2-bromophenyl)propiononitrile
C16H14BrN
Acta Crystallographica Section C (2006) 62, 9 o583-o586
a=9.7924(2)Å b=14.8921(2)Å c=10.0937(2)Å
α=90.00° β=113.392(2)° γ=90.00°
Methyl 2-benzyl-2-cyano-3-phenylpropionate
C18H17NO2
Acta Crystallographica Section C (2006) 62, 9 o583-o586
a=9.2000(3)Å b=9.3280(2)Å c=18.3031(5)Å
α=90.00° β=90.00° γ=90.00°
(E)-2-(2-thienyl)-3-(3,4,5-trimethoxyphenyl)acrylonitrile
C16H15NO3S1
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=22.5423(6)Å b=8.4647(3)Å c=7.4243(2)Å
α=90.00° β=91.510(2)° γ=90.00°
(E)-3-phenyl-2-(3-thienyl)acrylonitrile
C13H9NS
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=9.6280(11)Å b=5.7190(3)Å c=19.247(2)Å
α=90.00° β=103.129(7)° γ=90.00°
5-(2-Hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-3-methyl-2-(methylsulfanyl)- 6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-one monohydrate
C22H23N3O3S,H2O
Acta Crystallographica Section C (2006) 62, 9 o554-o556
a=9.11880(12)Å b=11.3095(2)Å c=11.6526(2)Å
α=97.5471(10)° β=110.5868(10)° γ=104.4677(11)°
3-[5-(4-Bromophenyl)-1H-pyrazol-3-ylamino]-5,5-dimethylcyclohex- 2-en-1-one--(Z)-3-(4-bromophenyl)-3-chloroacrylonitrile (2:1)
2C17H18BrN3O,C9H5BrClN
Acta Crystallographica Section C (2006) 62, 10 o608-o611
a=13.4390(4)Å b=13.8680(4)Å c=46.1620(15)Å
α=90.00° β=93.050(2)° γ=90.00°
3,7-diamino-2,5-dimethylpyrazolo[1,5-a]pyrimidine monohydrate
C8H11N5,H2O
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=8.0970(2)Å b=9.8881(3)Å c=11.9661(3)Å
α=90.00° β=96.230(5)° γ=90.00°
(E)-3-(4-bromophenyl)-2-(2-thienyl)acrylonitrile
C13H8BrNS
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=3.8557(2)Å b=24.0484(7)Å c=12.5466(4)Å
α=90.00° β=96.877(2)° γ=90.00°
2,5-Dimethyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C16H15N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=7.9430(19)Å b=7.9660(11)Å c=9.943(3)Å
α=87.637(13)° β=82.632(18)° γ=89.941(17)°
2-tert-Butyl-5-methyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C19H21N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=11.2632(5)Å b=11.4574(7)Å c=12.1317(6)Å
α=93.449(5)° β=90.313(4)° γ=102.791(6)°
1-deoxy-1-morpholino-D-fructopyranose
C10H19NO6
Acta Crystallographica Section C (2007) 63, 9 o507-o509
a=5.2767(8)Å b=5.5375(5)Å c=10.2809(13)Å
α=104.598(10)° β=90.393(12)° γ=104.834(10)°
Methyl 3-nitro-4-[(5-phenyl-1<i>H</i>-pyrazol-3-yl)amino]benzoate
C17H14N4O4
Acta Crystallographica Section C (2007) 63, 9 o510-o513
a=31.0506(4)Å b=5.4210(11)Å c=20.7251(12)Å
α=90.00° β=121.071(6)° γ=90.00°
5-Amino-1-(4-methoxybenzoyl)-3-methylpyrazole
C12H13N3O2
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=6.1920(15)Å b=9.192(2)Å c=10.546(2)Å
α=73.69(2)° β=85.634(17)° γ=82.83(3)°
5-Amino-3-methyl-1-(2-nitrobenzoyl)pyrazole
C11H10N4O3
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=11.4212(15)Å b=7.1787(14)Å c=13.2595(10)Å
α=90.00° β=90.00° γ=90.00°
2-[6-amino-3-methyl-2-(methylsulfanyl)-4-oxo-3,4-dihydropyrimidin- 5-ylcarbonyl]acetonitrile
C9H10N4O2S
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=6.6449(3)Å b=8.7262(3)Å c=9.4092(2)Å
α=76.390(3)° β=81.079(2)° γ=82.654(4)°
2-(6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5- ylcarbonyl)acetonitrile
C9H10N4O3
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=22.488(3)Å b=5.0709(5)Å c=18.6139(17)Å
α=90.00° β=116.956(7)° γ=90.00°
2-cyano-<i>N</i>-[6-chloro-2-(methylsulfanyl)pyrimidin-4-yl]acetamide
C8H7ClN4OS
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=12.8655(7)Å b=8.4390(2)Å c=9.9327(15)Å
α=90.00° β=108.827(13)° γ=90.00°
2-cyano-<i>N</i>-[6-methoxy-2-(methylsulfanyl)pyrimidin-4-yl]acetamide
C9H10N4O2S
Acta Crystallographica Section C (2008) 64, 3 o149-o154
a=17.106(3)Å b=11.8218(13)Å c=13.7187(19)Å
α=90.00° β=127.836(8)° γ=90.00°
2-Hydroxyphenyl 2-methylpyrazolo[1,5-a]pyrimidin-6-yl ketone
C14H11N3O2
Acta Crystallographica Section C (2000) 56, 12 1455-1456
a=5.6004(2)Å b=11.8172(5)Å c=17.865(7)Å
α=90.00° β=98.71(16)° γ=90.00°
5,5-dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one
C12H17N3O
Acta Crystallographica Section C (2000) 56, 12 1457-1459
a=12.5130(3)Å b=9.4275(3)Å c=10.6441(3)Å
α=90.00° β=90.00° γ=90.00°
2,4-bis(2-hydroxybenzoyl)-2,3-dihydro-1H-pyrido[2,1-b][1,3]benzothiazole
C25H19NO4S
Acta Crystallographica Section C (2000) 56, 12 1460-1461
a=7.4978(15)Å b=11.265(2)Å c=12.322(3)Å
α=108.12(3)° β=99.38(3)° γ=94.75(3)°
5-(ethylcarboxylate)-6-methoxy-2-pyrimidinamine
C9H12N2O3
Acta Crystallographica Section C (2001) 57, 9 1103-1105
a=7.4906(2)Å b=10.2409(2)Å c=13.1449(3)Å
α=104.9607(9)° β=90.7398(9)° γ=101.2452(9)°
2-Phenyl-5-p-tolyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C23H21N3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=8.5292(12)Å b=10.7291(16)Å c=11.0469(16)Å
α=109.417(2)° β=91.555(3)° γ=110.945(3)°
5-(4-Bromophenyl)-2-phenyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C22H18BrN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=8.5110(2)Å b=10.7015(3)Å c=11.0357(3)Å
α=110.036(2)° β=92.1613(15)° γ=110.3276(10)°
2-(4-Chlorophenyl)-5-phenyl-1,5,6,10b-tetrahydropyrazolo[1,5-c]quinazoline
C22H18ClN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=21.2115(3)Å b=11.1385(2)Å c=17.5948(4)Å
α=90° β=122.4270(10)° γ=90°
5-[N-(Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole
C20H22N6
Acta Crystallographica Section C (2002) 58, 6 o314-o317
a=7.2380(5)Å b=11.9743(9)Å c=21.2062(16)Å
α=90.00° β=90.00° γ=90.00°
5-(4-Bromophenyl)-2-(4-chlorophenyl)-1,5,6,10b-tetrahydropyrazolo[1,5-c] quinazoline
C22H17BrClN3
Acta Crystallographica Section C (2002) 58, 5 o305-o310
a=5.55600(10)Å b=12.2526(2)Å c=14.0827(3)Å
α=77.9230(9)° β=83.0060(8)° γ=87.8140(10)°
2-Aminobenzimidazolium O-ethyl malonate
C7H8N31,C5H7O41
Acta Crystallographica Section C (2003) 59, 12 o669-o671
a=12.0121(2)Å b=10.5379(2)Å c=20.8249(6)Å
α=90.00° β=94.7550(8)° γ=90.00°
2,2'-Methylenebis(3-hydroxy-5,5-dimethylcyclohex-2-en-1-one)
C17H24O4
Acta Crystallographica Section C (2003) 59, 12 o666-o668
a=18.8968(4)Å b=18.8989(4)Å c=8.7038(2)Å
α=90.00° β=90.00° γ=90.00°
1,5-Bis(4-chlorophenyl)-3-(2-chloroquinolin-3-yl)pentane-1,5-dione
C26H18Cl3NO2
Acta Crystallographica Section C (2006) 62, 1 o39-o41
a=11.2405(2)Å b=18.8738(3)Å c=21.0529(3)Å
α=90.00° β=90.00° γ=90.00°
5-Chloro-3-methyl-4-[3-(4-nitrophenyl)-4,5-dihydro-1H-pyrazol-5-yl]-1-phenyl- 1H-pyrazole
C19H16ClN5O2
Acta Crystallographica Section C (2006) 62, 1 o30-o32
a=5.5055(2)Å b=11.8317(3)Å c=13.5668(4)Å
α=83.3210(17)° β=78.9560(17)° γ=86.3960(18)°
4,5,6-Triamino-2-(methylsulfanyl)pyrimidine
C5H9N5S
Acta Crystallographica Section C (2006) 62, 3 o142-o144
a=7.7824(2)Å b=8.9623(3)Å c=10.5078(4)Å
α=90.00° β=95.261(2)° γ=90.00°
2-ethylsulfanyl-7-methyl-4-(4-methylphenyl)pyrazolo[1,5-a][1,3,5]triazine
C15H16N4S
Acta Crystallographica Section C (2006) 62, 3 o122-o124
a=16.0941(5)Å b=5.5573(2)Å c=15.2495(5)Å
α=90.00° β=96.2994(17)° γ=90.00°
2-ethylsulfanyl-7-methyl-4-(4-nitrophenyl)pyrazolo[1,5-a][1,3,5]triazine
C14H13N5O2S
Acta Crystallographica Section C (2006) 62, 3 o122-o124
a=7.9401(2)Å b=8.8642(3)Å c=11.3717(4)Å
α=68.7710(17)° β=85.792(2)° γ=72.214(2)°
5-methyl-2-phenyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.6223(2)Å b=16.7937(7)Å c=24.4900(9)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-(4-methylphenyl)-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.2767(13)Å b=29.924(6)Å c=8.0463(12)Å
α=90.00° β=112.590(6)° γ=90.00°
7-methyl-10-phenyl-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=8.10920(10)Å b=11.7265(2)Å c=16.3486(3)Å
α=90.00° β=90.9010(12)° γ=90.00°
7-methyl-10-(4-methylphenyl)-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.9037(7)Å b=13.1038(10)Å c=16.0576(13)Å
α=90.00° β=99.199(6)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)propenone
C20H17ClN2O2
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=12.7985(10)Å b=4.0684(3)Å c=16.6766(14)Å
α=90.00° β=95.918(4)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(3,4,5- trimethoxyphenyl)propenone
C22H21ClN2O4
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=7.5118(2)Å b=8.8121(3)Å c=15.6709(4)Å
α=81.8250(10)° β=82.750(2)° γ=79.459(2)°
1-(6-Amino-1,3-benzodioxol-5-yl)-3-(4-pyridyl)prop-2-en-1-one
C15H12N2O3
Acta Crystallographica Section C (2007) 63, 2 o99-o101
a=10.1044(3)Å b=11.7533(5)Å c=12.1655(5)Å
α=117.232(2)° β=97.480(3)° γ=99.585(2)°
2-amino-6-(methylanilino)pyrimidin-4(3H)-one
C11H12N4O
Acta Crystallographica Section C (2007) 63, 12 o697-o700
a=10.6860(12)Å b=7.1647(14)Å c=14.4911(12)Å
α=90.00° β=110.024(9)° γ=90.00°
2-amino-6-(methylanilino)-5-nitropyrimidin-4(3H)-one
C11H11N5O3
Acta Crystallographica Section C (2007) 63, 12 o697-o700
a=8.955(3)Å b=11.2165(15)Å c=11.5670(15)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-3-{2-Amino-4-ethoxy-6-[<i>N</i>-(4-methoxyphenyl)-N- methylamino]pyrimidin-5-yl}-1-phenylprop-2-en-1-one
C23H24N4O3
Acta Crystallographica Section C (2007) 63, 12 o758-o760
a=10.1975(14)Å b=10.959(2)Å c=11.046(2)Å
α=94.079(16)° β=109.845(11)° γ=113.339(10)°
7-(4-chlorophenyl)-2-ethylsulfanyl-4-phenylpyrazolo[1,5-a][1,3,5]triazine
C19H15ClN4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=11.8290(10)Å b=7.5703(5)Å c=19.5297(5)Å
α=90.00° β=107.200(3)° γ=90.00°
4,7-bis(4-chlorophenyl)-2-(ethylsulfanyl)pyrazolo[1,5-a][1,3,5]triazine
C19H14Cl2N4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=7.7117(4)Å b=8.3261(10)Å c=27.678(3)Å
α=90.00° β=94.978(5)° γ=90.00°
2-ethylsulfanyl-7-(4-methylphenyl)-4-phenylpyrazolo[1,5-a][1,3,5]triazine
C20H18N4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=4.8076(3)Å b=11.6397(5)Å c=15.5010(7)Å
α=92.164(4)° β=96.217(5)° γ=100.087(4)°
Ethyl (E)-3-[2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl]-2-cyanoacrylate
C14H20N6O2
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=8.5570(15)Å b=9.893(2)Å c=9.9739(18)Å
α=87.534(13)° β=77.251(15)° γ=67.431(14)°
2-[(2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene]malononitrile
C18H23N7
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=9.6960(8)Å b=14.752(3)Å c=15.418(3)Å
α=116.332(13)° β=96.794(10)° γ=93.587(9)°
Dispiro[indene-2,5'-indeno[2,1-a]fluorene-6',2''-indene]- 1,1'',3,3'',11',12'-hexaone
C36H16O6
Acta Crystallographica Section C (2008) 64, 3 o162-o165
a=8.2209(11)Å b=16.552(3)Å c=18.423(3)Å
α=90.00° β=97.775(19)° γ=90.00°
6-amino-3-methyl-2-(morpholin-4-yl)-5-nitrosopyrimidin-4(3H)-one
C9H13N5O3
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=8.9122(6)Å b=11.9051(7)Å c=10.4111(4)Å
α=90.00° β=105.649(3)° γ=90.00°
6-amino-2-(morpholin-4-yl)-5-nitrosopyrimidin-4(3H)-one hemihydrate
C8H11N5O3,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=16.421(2)Å b=7.3671(12)Å c=17.205(4)Å
α=90.00° β=104.794(12)° γ=90.00°
Ethyl 2-methoxy-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O3P
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5336(18)Å b=11.063(3)Å c=13.426(3)Å
α=73.722(18)° β=72.389(16)° γ=85.93(2)°
Ethyl 2-methylsulfanyl-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O2PS
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5671(14)Å b=11.0617(6)Å c=13.547(2)Å
α=102.987(8)° β=106.417(12)° γ=94.596(10)°
(2SR,4RS)-7-Chloro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=10.5798(8)Å b=5.3448(10)Å c=12.873(3)Å
α=90.00° β=90.204(12)° γ=90.00°
(2RS,4RS)-7-Chloro-2-<i>endo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.2855(10)Å b=15.649(2)Å c=17.880(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,4<i>R</i>)-7-fluoro-2-endo-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.4172(2)Å b=8.0164(6)Å c=16.2310(11)Å
α=90.00° β=96.745(4)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-trifluoromethoxy- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C15H11BrF3NO2S
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.6913(6)Å b=10.1187(6)Å c=13.2996(13)Å
α=90.00° β=100.497(8)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>-(2-chlorophenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=7.4328(11)Å b=12.3746(16)Å c=14.9187(19)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>- (1-naphthyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C20H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=9.6174(18)Å b=11.558(3)Å c=13.465(4)Å
α=90.00° β=90.00° γ=90.00°
2-<i>tert</i>-Butyl-5-methyl-7,8-dihydro-6<i>H</i>- cyclopenta[<i>e</i>]pyrazolo[1,5-<i>a</i>]pyrimidine
C14H19N3
Acta Crystallographica Section C (2008) 64, 9 o471-o473
a=6.8665(6)Å b=9.4084(14)Å c=11.147(2)Å
α=91.611(14)° β=107.728(14)° γ=111.097(12)°
9-Benzoyl-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione
C24H26O4
Acta Crystallographica Section C (2008) 64, 10 o554-o557
a=11.6394(15)Å b=11.5736(15)Å c=30.782(4)Å
α=90.00° β=90.00° γ=90.00°
(2SR,4RS)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-fluoro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C14H11BrFNOS
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=8.1835(6)Å b=10.9447(8)Å c=14.6940(12)Å
α=90.00° β=104.969(6)° γ=90.00°
(2SR,4RS)-7-Fluoro-2-<i>exo</i>-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy- 1-benzazepine
C14H12FNO2
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.5314(10)Å b=15.430(4)Å c=26.229(6)Å
α=90.00° β=92.960(17)° γ=90.00°
Hexamethylenediammonium bis(chloroacetate)
C6H18N22,2C2H2ClO2
Acta Crystallographica Section C (2008) 64, 9 o505-o507
a=6.5779(18)Å b=7.3593(10)Å c=8.425(2)Å
α=97.277(12)° β=95.631(15)° γ=111.037(12)°
(2SR,4RS)-7-chloro-2-<i>exo</i>-(4-chlorophenyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=11.9348(11)Å b=21.617(2)Å c=5.3024(6)Å
α=90.00° β=90.00° γ=90.00°